L Tumiotto
Overview
Explore the profile of L Tumiotto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
65
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toffoli G, Tumiotto L, Gigante M, Perin T, Biscontin G, Boiocchi M
Cancer Detect Prev
. 1993 Jan;
17(3):425-32.
PMID: 8402730
The cytotoxic efficacy of doxorubicin (DOX), vincristine (VCR), actinomycin-D (ACT-D), and teniposide (VM-26) toward the LoVo and SW948 multidrug-resistant (MDR) cell sublines was significantly enhanced by the concomitant presence of...
2.
Toffoli G, Tumiotto L, Gigante M, DallArche M, Perin T, Boiocchi M
Eur J Cancer
. 1993 Jan;
29A(12):1776-8.
PMID: 8398309
Resistance modifying agents (RMA) such as verapamil (VER) have proved effective in reversing multidrug resistance (MDR) in many in vitro experimental models, but clinical results with RMA have been disappointing....
3.
Viel A, Giannini F, Tumiotto L, Sopracordevole F, Visentin M, Boiocchi M
Br J Cancer
. 1992 Dec;
66(6):1030-6.
PMID: 1360809
In this study, 44 primary or metastatic human ovarian tumours were tested for allelic deletions on the short arm of chromosome 11. Analysis of 12 polymorphic loci by Southern blotting...
4.
Boiocchi M, Tumiotto L, Giannini F, Viel A, Biscontin G, Sartor F, et al.
Tumori
. 1992 Jun;
78(3):159-66.
PMID: 1359686
The biochemical bases of the multidrug-resistant (MDR) phenotype were investigated in drug-resistant sublines derived from LoVo human colon carcinoma cell lines by doxorubicin (DOX) and teniposide (VM26) selection. In addition...
5.
Toffoli G, Frustaci S, Tumiotto L, Talamini R, Gherlinzoni F, Picci P, et al.
Ann Oncol
. 1992 Jan;
3(1):63-9.
PMID: 1606072
Human soft tissue sarcomas (HSTS) in adults are a family of mesenchymal tumors characterized by high biological aggressiveness and general refractoriness to chemotherapy. A series of 36 HSTS, 24 untreated...
6.
Toffoli G, Viel A, Tumiotto L, Maestro R, Biscontin G, Boiocchi M
Cancer Chemother Pharmacol
. 1992 Jan;
29(4):283-9.
PMID: 1537074
To investigate whether mdr1 gene products are involved in conferring the chemoresistant phenotype to human colorectal carcinomas (HCCs), we determined the mdr1 mRNA expression level (mdr1 EL) in surgical specimens...
7.
Toffoli G, Viel A, Tumiotto L, Giannini F, Volpe R, Quaia M, et al.
Eur J Cancer
. 1992 Jan;
28A(8-9):1441-6.
PMID: 1515267
Expression of glutathione-S-transferase-pi (GST-pi) gene was quantitatively analysed on various human tumours (renal cell, colorectal, head and neck, ovarian carcinomas, soft tissue sarcomas; non-Hodgkin lymphomas) and on the corresponding normal...
8.
Viel A, De Pascale L, Toffoli G, Tumiotto L, Miotto E, Boiocchi M
Tumori
. 1991 Feb;
77(1):16-20.
PMID: 1708177
Fourteen human adenocarcinoma specimens were analyzed for somatic abnormalities affecting genes of the ras family. No amplification of the 3 ras genes was detected. Allelic deletion of the Ha-rasl gene...
9.
Toffoli G, Viel A, Tumiotto L, Biscontin G, Rossi C, Boiocchi M
Br J Cancer
. 1991 Jan;
63(1):51-6.
PMID: 1671208
The biochemical basis of multidrug-resistant (MDR) phenotype has been investigated in drug-resistant sublines independently obtained in our laboratories by single step doxorubicin (DOX) selection of LoVo, DLD1, and SW948 human...
10.
Toffoli G, Viel A, Tumiotto L, Buttazzi P, Biscontin G, Boiocchi M
Tumori
. 1989 Oct;
75(5):423-8.
PMID: 2690431
Ha-ras-transformed NIH3T3 fibroblasts were compared with the parental cell line to investigate the influence of the Ha-ras oncogene on cellular chemosensitivity to antineoplastic drugs. Four NIH3T3 cell clones independently transformed...